A new study published in the Journal of Chromatography A presents a sensitive method for the quantification of apidaecins, a type of antimicrobial peptide that play an important role the immune response of honey bees to pathogens. The method was developed using reversed-phase nanoliquid chromatography coupled with high resolution mass spectrometry (LC–MS) to determine apidaecins in hemolymph or body parts from individual honey bees.
Page 7
(Photo Credit: Getty Images) A new study published in the Journal of Chromatography A presents a sensitive method for the quantification of apidaecins, a type of antimicrobial peptide that play an important role the immune response of honey bees to pathogens.1 The method was developed using reversed-phase nanoliquid chromatography coupled with high resolution mass spectrometry (LC–MS) to determine apidaecins in hemolymph or body parts from individual honey bees.
There are three defence mechanisms that make up the immunity of honey bees: physical, cellular, and humoral. Antimicrobial peptides make up a key part of honey bee humoral immunity but, according to lead author Jiri Danihilik, the majority of published research is focused on the quantitation and analysis of gene expression. Danihilik told The Column: “Some groups have reported quantitative studies also on the peptide level determined in bee haemolymph by HPLC methods using UV detection, but the limited sensitivity of this methodology required sampling of hundreds of bee individuals.”
The study authors set out with the objective of developing an analytical method to quantify bee antimicrobial peptides in individual bees or their body parts. Danihilik told The Column: “We started with the smallest one, apidaecin, which [was] revealed to be quite challenging due to its very high basicity complicating sample preparation, storage, and chromatographic analysis.”
Honey bees were collected in the summer of 2012 in the Czech Republic from a private apiary. Samples were dissected and extracted and then analyzed by nanocapillary LC–MS. Danihilik told The Column: “We use a homogenate from freshly emerged bees to protect losses of the synthetic standard during calibration. Without this, you would see your precious peptide adsorbed to whatever surfaces it encounters on its way from the homogenization tube to LC–MS detector.”
The method was successfully performed to analyze apidaecin 1 isoforms in hemolymph, thoraxes, and heads. The authors state that the method is a proof-of-concept for the analysis of basic antimicrobial peptides in other organisms. Danihilik said: “Antimicrobial peptides are a hot topic in science and medicine in relation to emerging bacterial resistance to classical antibiotics, and this kind of quantification method can be very useful for further research in this area. Concerning the bees, our approach enables to quantify apidaecin peptide in single bees. In this way we can confirm that active peptides are present in small amounts even in ‘clinically healthy’ bees which were not previously challenged by pathogen infection.” - B.D.
Reference
1. J. Danihilik et al., Journal of Chromatography A 1374, 134–144 (2014).
This article is from The Column. The full issue can be found here>>
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.